SCHAUMBURG, Ill., Oct. 26 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company with a focus on injectable products, today announced that Jeffery M. Yordon, chief executive officer, founder and chairman of the board of Sagent Pharmaceuticals, has accepted invitations to present at upcoming conferences sponsored by Oppenheimer & Co. Inc. and Lazard Capital Markets LLC.
Two weeks following, Mr. Yordon will present at the Lazard Capital Markets 6th Annual Healthcare Conference at 10:55am Eastern Time on Tuesday, November 17, 2009. This conference, which is being held November 17-18 at the St. Regis Hotel in New York, NY, will feature presentations from 150 leading healthcare companies, five expert panel discussions, a “Conference Top Picks” panel with Lazard Capital Markets research analysts, and Senator Tom Daschle as the keynote speaker, on “Solving the Healthcare Crisis.”
To Discover Injectables Excellence(TM) and learn more about Sagent, please visit www.SagentPharma.com.
CONTACT: Investors, Ronald Pauli of Sagent Pharmaceuticals, Inc.,
+1-847-908-1604; or Media, Aline Schimmel of WeissComm Partners,
+1-312-646-6295, for Sagent Pharmaceuticals, Inc.
Web site: http://www.SagentPharma.com/
